0KUR4KZ
Supplement Upper Leg Muscle, Left to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | K Muscles |
| Operation | U Supplement |
| Body Part | R Upper Leg Muscle, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures in the muscle body system involve placing biological or synthetic material - such as surgical mesh, an acellular tissue matrix, or a patch graft - onto or into a muscle to reinforce it or restore some of its function, without replacing the muscle tissue itself. This approach is common in complex hernia repairs where the abdominal wall muscles are reinforced with mesh, in diaphragm reconstruction after a large defect, and in augmenting a weakened or partially torn muscle such as during certain rotator cuff procedures.
The goal is structural support rather than removal or replacement: the patient's own muscle stays in place, and the added material acts like an internal scaffold or patch that shares the load and encourages the surrounding tissue to heal with less risk of the defect reopening. This differs from procedures aimed at cutting out diseased tissue - Supplement is about strengthening what remains.
Anatomy & Axis Detail
Upper Leg Muscle, Left
On the left thigh, the quadriceps, hamstring, and adductor muscle groups provide the primary force for knee extension, hip stabilization, and ambulation. Supplement is indicated when this muscle bulk is diminished, such as after chronic quadriceps atrophy from prolonged immobilization, following sarcoma resection leaving a residual muscle deficit, or when reinforcing tissue over an orthopedic implant, distinct from suturing a torn muscle or removing damaged tissue. Surgeons place dermal substitute or synthetic mesh against the thinned muscle to restore contour and mechanical support, sometimes in conjunction with staged flap reconstruction. Because the femoral vessels and sciatic nerve traverse this region within distinct fascial compartments, the operative report should specify which thigh compartment was augmented, allowing the correct anterior, posterior, or medial body part value to be selected.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders need explicit documentation that graft or mesh material was implanted to reinforce or augment the muscle, including the material type (synthetic mesh, xenograft, allograft, etc.), since this determines the device value in the code. A note that only describes suturing torn muscle edges together, with no mention of an added material, does not support Supplement. A frequent error is coding Supplement when the surgeon actually performed a straightforward Repair by suturing without any implanted material, or the reverse - missing a Supplement code when mesh reinforcement is mentioned only briefly within a longer operative narrative for a different primary procedure.